
Zealand Pharma acquires Encycle
Under the agreement, Zealand Pharma A/S will acquire all outstanding shares in Encycle Therapeutics Inc., and all its intellectual property,...

CHMP selects drugs for EU market approval
The Committee supported the very first conditional marketing authorisation for Merck Sharp & Dohme B.V.’s Ervebo (Ebola Zaire Vaccine...

EMA greenlights new medicines
With the three innovative medicines and four generics the number of recommended medicines raised to 47 in 2019. The Committee saw a positive...

Zelluna Immunotherapy and Glycostem Therapeutics in licence deal
TCR cell therapy specialist Zelluna Immunotherapy (Oslo) and NK cell manufacturing specialist Glycostem Therapeutics BV (Oss) have entered into a...

Boehringer and Zealand to advance obesity drug
Boehringer is collaborating with Danish Zealand Pharma on a long-acting amylin analogue (BI 473494) and a GLP-1/glucagon dual-acting agonist (BI...

New method allows tracking of HIV
According to study leaders Prof. Christian Eggeling from Leibniz IPHT, Dr. Cyril Favard and Dr. Delphine Muriaux from the Montpellier Infectious...

NSCLC: Bemcentinib + anti-PD1 triple PFS
Bergen Bio ASA announced the primary endpoint of 25% Overall Response Rate (ORR) has been met in predominantly PD-L1 negative/low NSCLC patients in a...